Reaction
Right Ventricular Dysfunction reporting signals
As of the last recalculation, Right Ventricular Dysfunction appears in 1,063 FAERS reports alongside 27 co-occurring drug terms. The strongest observed disproportionality signal is SILDENAFIL POWDER, (PRR 49.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Sildenafil Powder, | 83 | 49.4 | 49.6 |
| Epoprostenol | 29 | 44.6 | 44.7 |
| Eplerenone | 24 | 37.5 | 37.6 |
| Sildenafil | 95 | 35.2 | 35.2 |
| Selexipag | 41 | 32.3 | 32.3 |
| Macitentan | 97 | 30.1 | 30.1 |
| Sevoflurane | 12 | 28.6 | 28.6 |
| Bosentan | 61 | 25.1 | 25.1 |
| Riociguat | 39 | 24.3 | 24.3 |
| Treprostinil | 133 | 23.6 | 23.6 |
| Rocuronium Bromide | 12 | 20.2 | 20.2 |
| Sildenafil Citrate | 117 | 20.1 | 20.1 |
| 0Xygen | 42 | 17.3 | 17.4 |
| Oxygen | 42 | 17.3 | 17.4 |
| Tadalafil | 75 | 15.7 | 15.7 |
| Anti-Thymocyte Globulin (Rabbit) | 6 | 14.6 | 14.7 |
| Chlorthalidone | 8 | 13.6 | 13.6 |
| Tafamidis | 7 | 11.7 | 11.7 |
| Norepinephrine | 6 | 11.0 | 11.1 |
| Ambrisentan | 59 | 9.7 | 9.7 |
| Pertuzumab | 13 | 9.5 | 9.5 |
| Ranolazine | 5 | 9.4 | 9.4 |
| Brivaracetam | 4 | 8.7 | 8.7 |
| Dasatinib | 14 | 7.5 | 7.5 |
| Crizotinib | 4 | 6.2 | 6.2 |
| Ethyl Alcohol | 8 | 5.8 | 5.8 |
| Palivizumab | 4 | 5.1 | 5.1 |